APA-Zitierstil (7. Ausg.)

Martija, A. A., Krauß, A., Bächle, N., Doth, L., Christians, A., Krunic, D., . . . Pusch, S. (2023). EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma. Acta Neuropathologica Communications, 11(1), . https://doi.org/10.1186/s40478-023-01673-z

Chicago-Zitierstil (17. Ausg.)

Martija, Antoni Andreu, et al. "EMP3 Sustains Oncogenic EGFR/CDK2 Signaling by Restricting Receptor Degradation in Glioblastoma." Acta Neuropathologica Communications 11, no. 1 (2023). https://doi.org/10.1186/s40478-023-01673-z.

MLA-Zitierstil (9. Ausg.)

Martija, Antoni Andreu, et al. "EMP3 Sustains Oncogenic EGFR/CDK2 Signaling by Restricting Receptor Degradation in Glioblastoma." Acta Neuropathologica Communications, vol. 11, no. 1, 2023, https://doi.org/10.1186/s40478-023-01673-z.